Trial Structure Duration: 48 weeks of treatment Participants: 338 adults randomized 2:1:1:1:1:2:2 to placebo or retatrutide groups Doses tested: 1mg, 4mg, 8mg, 12mg (all with slow titration from 2mg starting dose) Lifestyle intervention: All participants received counseling on diet (500 kcal/day deficit) and exercise (150 min/week) Primary endpoint: Percent weight change at 24 weeks Key secondary endpoints: Weight change at 48 weeks, proportion achieving 5%, 10%, 15% loss The trial used a slow titration protocol to minimize side effects: all groups except the 1mg dose started at 2mg weekly and escalated every 4 weeks
When diagnoses rise shortly after starting a medication, that pattern often reflects finding something that was already there, Rashmi Roy, MD, FACS, coauthor of the white paper, said
doi:10.3389/fnut.2021.702802 Nymo, S., Coutinho, S., Jrgensen, J
Clean the chosen site with an alcohol swab and allow it to dry completely
Consult your doctor Please consult your doctor if you have a history of heart disease before taking Gthance Tablet
While there is no evidence that degraded tirzepatide becomes toxic, using ineffective medication represents a clinical risk